These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5452388)

  • 1. [Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].
    Held H; Kaminski B; von Oldershausen HF
    Diabetologia; 1970 Aug; 6(4):386-91. PubMed ID: 5452388
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of tolbutamide and glycodiazine in liver and kidney diseases].
    Held H; Eisert R; von Oldershausen HF
    Verh Dtsch Ges Inn Med; 1973; 79():1220-3. PubMed ID: 4790141
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases.
    Held H; Eisert R; von Oldershausen HF
    Arzneimittelforschung; 1973 Dec; 23(12):1801-7. PubMed ID: 4801689
    [No Abstract]   [Full Text] [Related]  

  • 4. [A comparative study of blood sugar, insulinemia and sulfamidemia after oral administration of 1 g of glymidine (glycodiazine)].
    Jaquet P; Soyfer JC; Aprile N; Cristau B; Codaccioni JL
    Diabete; 1971; 19(1):33-6. PubMed ID: 5571511
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activity of benzopyrene hydrolase in human liver-biopsy specimens in vitro and its relationship to the elimination speed of glycodiazine in vivo].
    Held H; Schoene B; Laar HJ; Fleischmann R
    Verh Dtsch Ges Inn Med; 1974; 80():501-3. PubMed ID: 4454601
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfanilate clearance in clinical renal disease in the dog.
    Carlson GP; Kaneko JJ
    J Am Vet Med Assoc; 1971 Apr; 158(7):1235-9. PubMed ID: 5577418
    [No Abstract]   [Full Text] [Related]  

  • 7. [2-Benzolsulfonamido-5(beta-methoxy-ethoxy)-pyrimidine (Glycodiazine). II. Metabolism of 2-benzolsulfonamido-5(beta-hydroxy-ethoxy)-pyrimidine, a blood sugar reducing metabolite of glycodiazine in man].
    Gerhards E; Kolb KH
    Arzneimittelforschung; 1965 Dec; 15(12):1375-9. PubMed ID: 5899812
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of pharmacokinetics of oral antidiabetics from drug interference and renal insufficiency].
    Berger W; Spring P
    Dtsch Med Wochenschr; 1970 Dec; 95(50):2525-7. PubMed ID: 5488752
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Disease Pathologies on Transporter Expression and Function.
    Atilano-Roque A; Roda G; Fogueri U; Kiser JJ; Joy MS
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S205-21. PubMed ID: 27385176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation of biologic effect to dispersion grade. 3].
    Reetz W; Speiser P
    Pharm Acta Helv; 1970 Aug; 45(8):461-79. PubMed ID: 5494126
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics of antihypertensive drugs in kidney and liver diseases].
    Knauf H; Mutschler E
    MMW Munch Med Wochenschr; 1983 Nov; 125(45):1037-40. PubMed ID: 6139750
    [No Abstract]   [Full Text] [Related]  

  • 12. [Doxycycline (Vibramycin) in restricted renal function].
    Porpáczy P
    Wien Klin Wochenschr; 1970 Oct; 82(41):710-4. PubMed ID: 5480598
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of oxytetracycline in renal insufficiency].
    Mérier G; Rudhardt M; Herrera A; Wasem R; Fabre J
    Schweiz Med Wochenschr; 1970 Aug; 100(34):1442-6. PubMed ID: 5524916
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of disease on the metabolism and effects of drugs in man].
    Lavigne JG
    Union Med Can; 1980 Dec; 109(12):1718-22. PubMed ID: 7210314
    [No Abstract]   [Full Text] [Related]  

  • 15. [Affecting the blood sugar lowering action of oral antidiabetics by other drugs and renal insufficiency].
    Berger W; Spring P
    Internist (Berl); 1970 Dec; 11(12):436-41. PubMed ID: 4924815
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of organ dysfunction on drug dosing.
    Egorin M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):116-8. PubMed ID: 16728919
    [No Abstract]   [Full Text] [Related]  

  • 17. [Spectrofluorometric method for determination of glycodiazine in plasma and of the both glycodiazine metabolites in urine].
    Held H; Kaminski B; von Oldershausen HF
    Arzneimittelforschung; 1970 Dec; 20(12):1927-9. PubMed ID: 5537100
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies with alkylating esters. I. The fate of ethylene dimethanesulphonate.
    Edwards K; Craig AW; Jackson H
    Biochem Pharmacol; 1969 Jul; 18(7):1693-700. PubMed ID: 4979843
    [No Abstract]   [Full Text] [Related]  

  • 19. Fate and metabolism of some mutagenic alkylating agents in the mouse. I. Ethyl methanesulfonate and methyl methanesulfonate at sublethal dose in hybrid males.
    Cumming RB; Walton MF
    Mutat Res; 1970 Oct; 10(4):365-77. PubMed ID: 5519682
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of inulin and sodium sulfanilate clearances in sheep and goats.
    Ruiz M; Parker HR
    Experientia; 1971; 27(11):1305-7. PubMed ID: 5134288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.